Association of serum 25-hydroxyvitamin D levels with aggressiveness of papillary thyroid cancer

Objective: Serum 25-hydroxyvitamin D (25(OH)D) deficiency has been known to be associated with the risk and mortality of several cancers. However, the role of 25(OH)D in papillary thyroid cancer (PTC) remains controversial. This study aimed to investigate the association between 25(OH)D and clinicop...

Full description

Bibliographic Details
Main Authors: Yuting Shao, Xiaole Hu, Yuxi Wang, Yi Shao, Luchuan Li, Qingdong Zeng, Hong Lai, Lei Sheng
Format: Article
Language:English
Published: Bioscientifica 2023-12-01
Series:Endocrine Connections
Subjects:
Online Access:https://ec.bioscientifica.com/view/journals/ec/13/1/EC-23-0373.xml
_version_ 1827584565724577792
author Yuting Shao
Xiaole Hu
Yuxi Wang
Yi Shao
Luchuan Li
Qingdong Zeng
Hong Lai
Lei Sheng
author_facet Yuting Shao
Xiaole Hu
Yuxi Wang
Yi Shao
Luchuan Li
Qingdong Zeng
Hong Lai
Lei Sheng
author_sort Yuting Shao
collection DOAJ
description Objective: Serum 25-hydroxyvitamin D (25(OH)D) deficiency has been known to be associated with the risk and mortality of several cancers. However, the role of 25(OH)D in papillary thyroid cancer (PTC) remains controversial. This study aimed to investigate the association between 25(OH)D and clinicopathologic features of PTC. Methods: Patients who underwent thyroidectomy were retrospectively reviewed. Serum 25(OH)D levels were measured within a week prior to surgery. The patients were categorized into four quartiles according to season-specific 25(OH)D levels. The association between 25(OH)D levels and clinicopathologic features of PTC was analyzed. Results: A total of 2932 patients were enrolled in the study. The 25(OH)D levels were significantly higher in patients with lymph node metastasis (LNM; P < 0.001), lateral LNM (P < 0.001), and multifocal tumors (P < 0.001). Compared to the first quartile (Q1) of 25(OH)D level, the third quartile (Q3) and the fourth quartile (Q4) showed an unadjusted OR of 1.36 (95% CI: 1.09–1.69; P = 0.006) and 1.76 (95% CI: 1.42–2.19; P < 0.001) for LNM (P for trend < 0.001), respectively. An increased risk of multifocal tumors was strongly associated with high 25(OH)D concentration (P for trend <0.001). Similar results were obtained after adjusting for confounding factors. Conclusion: High 25(OH)D levels are associated with aggressive features of PTC, such as lymph node metastasis and multifocality.
first_indexed 2024-03-08T23:33:11Z
format Article
id doaj.art-d17253b144124158af95429772952dcc
institution Directory Open Access Journal
issn 2049-3614
language English
last_indexed 2024-03-08T23:33:11Z
publishDate 2023-12-01
publisher Bioscientifica
record_format Article
series Endocrine Connections
spelling doaj.art-d17253b144124158af95429772952dcc2023-12-14T10:38:41ZengBioscientificaEndocrine Connections2049-36142023-12-0113118https://doi.org/10.1530/EC-23-0373Association of serum 25-hydroxyvitamin D levels with aggressiveness of papillary thyroid cancerYuting Shao0Xiaole Hu1Yuxi Wang2Yi Shao3Luchuan Li4Qingdong Zeng5Hong Lai6Lei Sheng7Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, Shandong, ChinaDepartment of Operating Room, Qilu Hospital of Shandong University, Shandong, ChinaDepartment of Breast and Thyroid Surgery, People’s Hospital of Mengyin County, Linyi, Shandong, ChinaDepartment of Thyroid Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, ChinaDepartment of Thyroid Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, ChinaDepartment of Thyroid Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, ChinaDepartment of Endocrinology, Qilu Hospital of Shandong University, Jinan, Shandong, ChinaDepartment of Thyroid Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, ChinaObjective: Serum 25-hydroxyvitamin D (25(OH)D) deficiency has been known to be associated with the risk and mortality of several cancers. However, the role of 25(OH)D in papillary thyroid cancer (PTC) remains controversial. This study aimed to investigate the association between 25(OH)D and clinicopathologic features of PTC. Methods: Patients who underwent thyroidectomy were retrospectively reviewed. Serum 25(OH)D levels were measured within a week prior to surgery. The patients were categorized into four quartiles according to season-specific 25(OH)D levels. The association between 25(OH)D levels and clinicopathologic features of PTC was analyzed. Results: A total of 2932 patients were enrolled in the study. The 25(OH)D levels were significantly higher in patients with lymph node metastasis (LNM; P < 0.001), lateral LNM (P < 0.001), and multifocal tumors (P < 0.001). Compared to the first quartile (Q1) of 25(OH)D level, the third quartile (Q3) and the fourth quartile (Q4) showed an unadjusted OR of 1.36 (95% CI: 1.09–1.69; P = 0.006) and 1.76 (95% CI: 1.42–2.19; P < 0.001) for LNM (P for trend < 0.001), respectively. An increased risk of multifocal tumors was strongly associated with high 25(OH)D concentration (P for trend <0.001). Similar results were obtained after adjusting for confounding factors. Conclusion: High 25(OH)D levels are associated with aggressive features of PTC, such as lymph node metastasis and multifocality.https://ec.bioscientifica.com/view/journals/ec/13/1/EC-23-0373.xml25-hydroxyvitamin dpapillary thyroid canceraggressivenesslymph node metastasismultifocality
spellingShingle Yuting Shao
Xiaole Hu
Yuxi Wang
Yi Shao
Luchuan Li
Qingdong Zeng
Hong Lai
Lei Sheng
Association of serum 25-hydroxyvitamin D levels with aggressiveness of papillary thyroid cancer
Endocrine Connections
25-hydroxyvitamin d
papillary thyroid cancer
aggressiveness
lymph node metastasis
multifocality
title Association of serum 25-hydroxyvitamin D levels with aggressiveness of papillary thyroid cancer
title_full Association of serum 25-hydroxyvitamin D levels with aggressiveness of papillary thyroid cancer
title_fullStr Association of serum 25-hydroxyvitamin D levels with aggressiveness of papillary thyroid cancer
title_full_unstemmed Association of serum 25-hydroxyvitamin D levels with aggressiveness of papillary thyroid cancer
title_short Association of serum 25-hydroxyvitamin D levels with aggressiveness of papillary thyroid cancer
title_sort association of serum 25 hydroxyvitamin d levels with aggressiveness of papillary thyroid cancer
topic 25-hydroxyvitamin d
papillary thyroid cancer
aggressiveness
lymph node metastasis
multifocality
url https://ec.bioscientifica.com/view/journals/ec/13/1/EC-23-0373.xml
work_keys_str_mv AT yutingshao associationofserum25hydroxyvitamindlevelswithaggressivenessofpapillarythyroidcancer
AT xiaolehu associationofserum25hydroxyvitamindlevelswithaggressivenessofpapillarythyroidcancer
AT yuxiwang associationofserum25hydroxyvitamindlevelswithaggressivenessofpapillarythyroidcancer
AT yishao associationofserum25hydroxyvitamindlevelswithaggressivenessofpapillarythyroidcancer
AT luchuanli associationofserum25hydroxyvitamindlevelswithaggressivenessofpapillarythyroidcancer
AT qingdongzeng associationofserum25hydroxyvitamindlevelswithaggressivenessofpapillarythyroidcancer
AT honglai associationofserum25hydroxyvitamindlevelswithaggressivenessofpapillarythyroidcancer
AT leisheng associationofserum25hydroxyvitamindlevelswithaggressivenessofpapillarythyroidcancer